Regulatory News:

The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 26, 2021) at 10:00 a.m. at the Company's headquarters (400 boulevard Gonthier d'Andernach - Parc d'Innovation - 67400 Illkirch-Graffenstaden - France) chaired by Hedi Ben Brahim, Chairman and CEO, to approve the Company’s financial statements for the year ended December 31, 2020 and to vote the other resolutions submitted to their approval. As a result of restrictions placed on the movement and gatherings of persons in the context of the COVID-19 pandemic, this General Meeting was held behind closed doors without the physical presence of its shareholders. Its replay is available via Transgene’s website and here.

At the Combined General Meeting, the shareholders adopted all resolutions recommended for approval by the Board of Directors.

Detailed voting results are available on Transgene's website, under the heading Investors > General Meeting.


Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04


Citigate Dewe Rogerson David Dible/Sylvie Berrebi + 44 (0)20 7638 9571

Grafico Azioni Transgene (EU:TNG)
Da Ago 2021 a Set 2021 Clicca qui per i Grafici di Transgene
Grafico Azioni Transgene (EU:TNG)
Da Set 2020 a Set 2021 Clicca qui per i Grafici di Transgene